Showing 181 - 200 of 207 results
A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.
Bushfires in proximity to ANSTO during the 2018 bushfires.
The nandin Deep Technology Incubator at ANSTO’s Lucas Heights innovation precinct has welcomed two new members.
Accurate ‘fingerprinting’ tool to verify source of origin is in development with collaborators from academia and industry.
Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.
Consortium will map the 86 billion nerve cells, 100 trillion connections and neurotransmitters in the human brain.
Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.
ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.
ANSTO joined the Australian delegation at the 68th General Conference of the International Atomic Energy Agency (IAEA) last month in Vienna, participating in a number of insightful side-events and fruitful bilateral partnership meetings.
Guide to successful proposals and experiments at the Powder Diffraction beamline.
See details of previously published customer updates from our Health products team.
ANSTO recognised the contribution of individuals and teams to nuclear science and technology at the 2023 ANSTO Awards Ceremony held on 25 July.
This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors safe and minimise the risk of the spread of COVID-19 infection.
The Australian Government recently signed a landmark emissions reduction technology deal with Great Britain, which includes nuclear energy and clean hydrogen among the six key low emission technologies the two countries hope to advance.
